drugset / Trial / NCT05049525
Evaluation of the Response of Itraconazole and Terbinafine Therapy in Subjects With Crohn's Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will evaluate the response of itraconazole and terbinafine therapy compared to placebo in patients with mild to moderate Crohn's disease (CD).
Timeline
- Start
- 2022-02-22
- Primary completion
- 2024-02-28
- Completion
- 2024-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Itraconazole | Small molecule | 200 mg | Oral |
| Comparator | Terbinafine | Small molecule | 250 mg | Oral |